LRRK2 and Parkinson disease: GAK is shown to interact with α-synuclein in a pathway involved with PD pathogenesis (Dumitriu et al, 2011) as well as to form part of a binding complex with another known PD-risk gene leucine-rich repeat kinase 2 (LRRK2) (Beilina et al, 2014).